EA. In most clinical trials comparing
transfemoral CAS with CEA, stroke, MI, and death have
been given equal weight in determining a composite
end point to test overall efÔ¨Åcacy. Data from the Carotid
Revascularization Endarterectomy vs Stenting Trial
(CREST),5 however, indicate that stroke has a more significant effect on quality of life at 1 year than nonfatal MI. In
developing its recommendations, the committee placed
